<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-155434" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Emphysematous Pyelonephritis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sherchan</surname>
            <given-names>Robin</given-names>
          </name>
          <aff>Baylor College of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hamill</surname>
            <given-names>Richard</given-names>
          </name>
          <aff>Baylor College of Medicine; Michael E. DeBakey VA Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Robin Sherchan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Richard Hamill declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>1</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-155434.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Emphysematous pyelonephritis (EPN) is a severe necrotizing infection that affects the upper urinary tract, involving the renal parenchyma and, in some instances, the perirenal tissues of the kidney.&#x000a0;This condition frequently leads to gas formation in the renal parenchyma, collecting system, or perinephric tissue.&#x000a0;Emphysematous pyelitis (gas in the renal pelvis) or emphysematous cystitis (gas within the bladder wall and lumen) may occur independently of associated EPN.&#x000a0;</p>
        <p>Diabetes mellitus represents the most prevalent risk factor, found in over 90% of patients diagnosed with&#x000a0;EPN.<xref ref-type="bibr" rid="article-155434.r1">[1]</xref>&#x000a0;EPN is a life-threatening disease, with reported mortality rates ranging from 40% to 90%.<xref ref-type="bibr" rid="article-155434.r2">[2]</xref>&#x000a0;Clinical diagnosis of the condition closely mirrors acute pyelonephritis, which requires&#x000a0;accurate evaluation through imaging, particularly&#x000a0;computed tomography (CT) scans.&#x000a0;Treatment options for EPN have evolved, with aggressive surgical intervention and more conservative therapeutic approaches, primarily involving percutaneous drainage and antimicrobials.<xref ref-type="bibr" rid="article-155434.r3">[3]</xref></p>
      </sec>
      <sec id="article-155434.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">Escherichia coli</italic> and<italic toggle="yes"> Klebsiella pneumoniae</italic> are the most common pathogens associated with EPN, accounting for 49% to 67% and 20% to 24% of cases, respectively. Other reported organisms include <italic toggle="yes">Proteus</italic>, <italic toggle="yes">Enterococcus</italic>, <italic toggle="yes">Clostridium</italic>, <italic toggle="yes">Aspergillus, </italic>and, rarely,&#x000a0;<italic toggle="yes"><italic toggle="yes">Candida </italic></italic>spp.&#x000a0;In some instances, infections exhibit polymicrobial characteristics.<xref ref-type="bibr" rid="article-155434.r3">[3]</xref><xref ref-type="bibr" rid="article-155434.r4">[4]</xref><xref ref-type="bibr" rid="article-155434.r5">[5]</xref><xref ref-type="bibr" rid="article-155434.r6">[6]</xref></p>
      </sec>
      <sec id="article-155434.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>In more than 90% of cases, patients with EPN have diabetes mellitus, obstructive uropathy, and hypertension as the most common risk factors.<xref ref-type="bibr" rid="article-155434.r1">[1]</xref><xref ref-type="bibr" rid="article-155434.r7">[7]</xref><xref ref-type="bibr" rid="article-155434.r8">[8]</xref>&#x000a0;Patients with EPN without diabetes typically present with immunocompromising conditions, including alcohol use disorder, tuberculosis, or acquired immunodeficiency syndrome. Prior history of urological procedures, previous antibiotic use, or hospitalization does not appear to be relevant risk factors for the development of EPN.</p>
        <p>EPN is more prevalent in&#x000a0;older patients&#x000a0;and females (4:1), likely because women typically have higher rates of urinary tract infections.<xref ref-type="bibr" rid="article-155434.r8">[8]</xref> Adverse outcome risk factors encompass advanced age, altered mentation, acute renal failure, thrombocytopenia, hypoalbuminemia, severe proteinuria, polymicrobial infections, and shock. The potential impact of geographical distribution is noted, with increased reported cases in Asia considered a contributing risk factor.<xref ref-type="bibr" rid="article-155434.r9">[9]</xref><xref ref-type="bibr" rid="article-155434.r10">[10]</xref></p>
      </sec>
      <sec id="article-155434.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Uncontrolled diabetes can cause bacterial propagation and disease progression due to high tissue glucose levels, impaired oxygen supply to the kidneys, and microvascular disease.<xref ref-type="bibr" rid="article-155434.r7">[7]</xref> Gas accumulation observed in EPN is likely a consequence of microbial fermentation of glucose and lactate, producing gases such as carbon dioxide, hydrogen, and nitrogen.<xref ref-type="bibr" rid="article-155434.r11">[11]</xref>&#x000a0;Urinary tract obstructions can reduce renal blood flow and tissue perfusion, exacerbating the infection.<xref ref-type="bibr" rid="article-155434.r12">[12]</xref></p>
      </sec>
      <sec id="article-155434.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The onset of symptoms of EPN&#x000a0;may unfold&#x000a0;suddenly or gradually over&#x000a0;2 to&#x000a0;3 weeks.&#x000a0;EPN may be clinically&#x000a0;indistinguishable from severe, acute pyelonephritis based on clinical presentation alone. Fevers, chills, dysuria, nausea, and vomiting are the presenting symptoms and signs of EPN. Other physical signs include abdominal pain, loin tenderness, and pneumaturia or palpable crepitus.<xref ref-type="bibr" rid="article-155434.r13">[13]</xref><xref ref-type="bibr" rid="article-155434.r14">[14]</xref></p>
      </sec>
      <sec id="article-155434.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Laboratory findings may include pyuria, leukocytosis, hyperglycemia, and elevated serum creatinine.<xref ref-type="bibr" rid="article-155434.r14">[14]</xref>&#x000a0;Bacteremia is also relatively common.&#x000a0;CT imaging is the most effective diagnostic tool to detect EPN in individuals with 100% sensitivity compared to ultrasonography (69%) and plain film radiography (65%).<xref ref-type="bibr" rid="article-155434.r7">[7]</xref>&#x000a0;</p>
        <p>
<bold>Classification</bold>
</p>
        <p>EPN can be classified into 3 different schemas based on radiological findings.</p>
        <p><bold>Michaeli et al classification:&#x000a0;</bold>In 1984, Michaeli et al first classified EPN based on the findings of plain abdominal film of the kidney, ureter, and bladder, and intravenous pyelogram.<xref ref-type="bibr" rid="article-155434.r15">[15]</xref>&#x000a0;The classification includes the below-mentioned stages.</p>
        <list list-type="bullet">
          <list-item>
            <p>Stage I: Gas in the renal parenchyma or perinephric tissue</p>
          </list-item>
          <list-item>
            <p>Stage&#x000a0;II: Gas in the kidney and its surroundings</p>
          </list-item>
          <list-item>
            <p>Stage III: Extension of gas through fascia or bilateral disease</p>
          </list-item>
        </list>
        <p><bold>Wan et al&#x000a0;classification:&#x000a0;</bold>In 1996, Wan et al introduced a classification system categorizing patients into 2 groups based on CT findings.<xref ref-type="bibr" rid="article-155434.r16">[16]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Type I: Renal necrosis with the presence of gas but no fluid</p>
          </list-item>
          <list-item>
            <p>Type&#x000a0;II: Parenchymal gas associated with fluid in the renal parenchyma, perinephric space, or collecting system&#x000a0;</p>
          </list-item>
        </list>
        <p><bold>Huang and Tseng classification:&#x000a0;</bold>In 2000, Huang and Tseng published a different classification based on the extent of disease observed on CT scans, providing a more detailed description with additional subcategories.<xref ref-type="bibr" rid="article-155434.r11">[11]</xref>&#x000a0;This classification system was grouped into 4 classes, as mentioned below.</p>
        <table-wrap id="article-155434.table0" position="float" orientation="portrait">
          <caption>
            <title>Table. Huang and Tseng Classification of EPN</title>
          </caption>
          <table style="width: 600px;" border="1" cellspacing="1" cellpadding="2">
            <tbody>
              <tr style="height: 16px;">
                <td style="width: 52.4464px; height: 16px;" rowspan="1" colspan="1">
<bold>Classes</bold>
</td>
                <td style="width: 610.554px; height: 16px;" rowspan="1" colspan="1">
<bold>Extent of Disease</bold>
</td>
              </tr>
              <tr style="height: 16px;">
                <td style="width: 52.4464px; height: 16px;" rowspan="1" colspan="1">
<bold>Class 1</bold>
</td>
                <td style="width: 610.554px; height: 16px;" rowspan="1" colspan="1">Gas is present only in the collecting system (ie, emphysematous pyelitis)</td>
              </tr>
              <tr style="height: 16px;">
                <td style="width: 52.4464px; height: 16px;" rowspan="1" colspan="1">
<bold>Class 2</bold>
</td>
                <td style="width: 610.554px; height: 16px;" rowspan="1" colspan="1">Gas is present in the renal parenchyma without extending to the extrarenal space</td>
              </tr>
              <tr style="height: 78px;">
                <td style="width: 52.4464px; height: 78px;" rowspan="1" colspan="1">
<bold>Class 3</bold>
</td>
                <td style="width: 610.554px; height: 78px;" rowspan="1" colspan="1">
<p>Extension into the extrarenal space is classified as follows:</p>
<list list-type="bullet"><list-item><p>Class 3A:&#x000a0;Extension of gas or abscess to the perinephric space</p></list-item><list-item><p>Class 3B: Extension of gas or abscess to the pararenal space</p></list-item></list>
</td>
              </tr>
              <tr style="height: 16.0001px;">
                <td style="width: 52.4464px; height: 16.0001px;" rowspan="1" colspan="1">
<bold>Class 4</bold>
</td>
                <td style="width: 610.554px; height: 16.0001px;" rowspan="1" colspan="1">Bilateral&#x000a0;EPN or a solitary functioning kidney with&#x000a0;EPN</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>The Huang and Tseng classification system has shown a correlation between a higher class, indicating more extensive disease, with an increased risk of unfavorable outcomes. Differentiating between classes is crucial for accurate prognosis and treatment planning. Emphysematous pyelitis, which responds well to antibiotic treatment alone, has a prognosis similar to pyelonephritis. In contrast, EPN, with a higher mortality rate, requires urgent procedural intervention (see <bold>Image</bold>. Emphysematous Pyelonephritis).</p>
      </sec>
      <sec id="article-155434.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Initial Approach</bold>
</p>
        <p>The initial treatment approach should involve aggressive resuscitation, ensuring adequate intravenous hydration, oxygen supply, blood sugar control by utilizing insulin, and the administration of broad-spectrum antibiotics.</p>
        <p>
<bold>Antibiotics</bold>
</p>
        <p>Empiric antibiotics should cover common bacteria, such as<italic toggle="yes"> E coli</italic>, <italic toggle="yes">K pneumoniae,</italic> and <italic toggle="yes">Proteus mirabilis,</italic>&#x000a0;that&#x000a0;cause urinary tract infections. Additional&#x000a0;consideration should be given to coverage for&#x000a0;<italic toggle="yes">Pseudomonas aeruginosa</italic> and <italic toggle="yes">Enterococcus </italic>species. The preferred single-agent treatment options may include third- or fourth-generation cephalosporins&#x000a0;or carbapenems. The administration of empiric antibiotics is crucial in&#x000a0;reducing the mortality rates in gram-negative systemic infections.</p>
        <p>An alternative option for combination therapy involves amikacin and a third-generation cephalosporin, given the low antibiotic resistance rates observed among <italic toggle="yes">E coli</italic>, <italic toggle="yes">K pneumoniae</italic>, and <italic toggle="yes">P mirabilis</italic> for amikacin.<xref ref-type="bibr" rid="article-155434.r8">[8]</xref> Fluoroquinolones should not be chosen as the primary option for empirical treatment due to the high levels of resistance resulting from their excessive use.<xref ref-type="bibr" rid="article-155434.r17">[17]</xref></p>
        <p>The transition from intravenous to oral antibiotics and the selection of specific antibiotics are typically guided by clinical improvement, as evidenced by the absence of fever, leukocytosis, and overall enhancement in the patient's well-being. This decision is complemented by culture and antimicrobial resistance testing results. The standard duration of treatment is 2 weeks, although it may vary based on individual cases.</p>
        <p>
<bold>Percutaneous drainage</bold>
</p>
        <p>In addition to antibiotics, percutaneous drainage is recommended for patients with EPN. Antibiotic treatment is likely sufficient for patients with isolated emphysematous pyelitis, and deferring drainage can be considered. Cultures from drainage should be obtained to guide antibiotic therapy. Importantly, urine culture results may not always align with drainage or surgical cultures.<xref ref-type="bibr" rid="article-155434.r4">[4]</xref><xref ref-type="bibr" rid="article-155434.r18">[18]</xref> The removal of the drainage catheter depends on clinical improvement, evidenced by decreased drain output while in the correct anatomical position.</p>
        <p>
<bold>Relief of obstruction</bold>
</p>
        <p>Relieving the obstruction is crucial when EPN is associated with urinary tract obstruction, such as hydronephrosis. This can be achieved through the use of percutaneous nephrostomy catheters or ureteral stents.</p>
        <p>
<bold>Nephrectomy</bold>
</p>
        <p>The preferred treatment for EPN has transitioned away from invasive operations, such as nephrectomy or open drainage, favoring more conservative approaches, such as percutaneous drainage with antibiotics.<xref ref-type="bibr" rid="article-155434.r7">[7]</xref><xref ref-type="bibr" rid="article-155434.r19">[19]</xref>&#x000a0;This transformation is likely attributable to improvements in imaging modalities, improved antibiotic practices, and advancements in drainage technology. These factors have contributed to a notable reduction in the mortality rate associated with EPN, now at 21%, down from historical rates ranging from 40% to 90%.<xref ref-type="bibr" rid="article-155434.r12">[12]</xref><xref ref-type="bibr" rid="article-155434.r20">[20]</xref></p>
        <p>In a meta-analysis conducted by Aboumarzouk et al, emergent nephrectomy, percutaneous drainage, and medical management alone were compared.<xref ref-type="bibr" rid="article-155434.r21">[21]</xref>&#x000a0;The overall mortality rate was approximately 18%, with both percutaneous drainage and medical management alone demonstrating significantly lower mortality rates compared to emergent nephrectomy.&#x000a0;Although, currently, nephrectomy is less commonly selected as the primary treatment, it may still be necessary for patients who do not respond to conservative therapy. The choice of nephrectomy type&#x02014;simple, radical, or laparoscopic&#x02014;depends on the patient's clinical condition and the extent of the disease.<xref ref-type="bibr" rid="article-155434.r22">[22]</xref>&#x000a0;Therefore, current treatment recommendations advocate using conservative strategies, such as endoscopic or percutaneous drainage, for renal preservation. Nephrectomy should only be considered if these approaches prove ineffective.<xref ref-type="bibr" rid="article-155434.r13">[13]</xref><xref ref-type="bibr" rid="article-155434.r23">[23]</xref></p>
        <p>
<bold>Management Approach</bold>
</p>
        <p>Huang and Tseng have proposed a management approach for EPN based on clinico-radiological classification,<xref ref-type="bibr" rid="article-155434.r11">[11]</xref><xref ref-type="bibr" rid="article-155434.r13">[13]</xref>&#x000a0;as mentioned below.</p>
        <p><bold>Classes 1 and 2 EPN:</bold> Medical management alone or combined with percutaneous drainage can yield favorable outcomes.</p>
        <p><bold>Classes 3A&#x000a0;and 3B EPN:</bold> These are further divided into 2 categories, as listed below.</p>
        <list list-type="bullet">
          <list-item>
            <p>In patients with fewer than&#x000a0;2 risk factors: Medical management plus percutaneous drainage yields&#x000a0;a survival rate of 85%.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>In&#x000a0;patients with more than&#x000a0;2 risk factors: Medical management plus percutaneous drainage proved unsuccessful in 92% of cases, with a higher proportion of patients requiring nephrectomy in this group.</p>
          </list-item>
        </list>
        <p>Risk factors associated with increased mortality include diabetes mellitus, thrombocytopenia, acute renal failure, altered level of consciousness, and shock.&#x000a0;</p>
        <p><bold>Class 4 EPN:&#x000a0;</bold>The initial step remains medical management plus percutaneous drainage.</p>
        <p>In any class of EPN, if&#x000a0;renal preservation with medical&#x000a0;management and percutaneous drainage proves unsuccessful, the subsequent step is nephrectomy.</p>
      </sec>
      <sec id="article-155434.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for EPN includes conditions that may present with similar clinical presentation or imaging findings. Some of the key differentials to consider are mentioned below.</p>
        <p><bold>Severe acute pyelonephritis:</bold>&#x000a0;This&#x000a0;condition entails inflammation of the renal parenchyma. Clinically, distinguishing EPN from severe acute pyelonephritis can be challenging; hence, imaging is&#x000a0;crucial in diagnosis.</p>
        <p><bold>Renal abscess:</bold>&#x000a0;This&#x000a0;condition is characterized by the accumulation of pus within the kidney, and it may present with symptoms resembling EPN, including fever, urinary symptoms, and flank pain. In some cases, gas production within the abscess can result in the presence of air in imaging studies.</p>
        <p><bold>Renal trauma:</bold> Blunt or penetrating injury to the kidney can disrupt tissue and blood vessels, allowing air entry into the renal parenchyma.</p>
        <p><bold>Renal infarction:</bold>&#x000a0;This condition results&#x000a0;from compromised blood flow to a part of the kidney, causing tissue damage.&#x000a0;Renal infarction&#x000a0;can present with similar symptoms and may sometimes be associated with gas in the renal parenchyma.</p>
        <p><bold>Gas-forming infections:</bold> Infections caused by gas-forming bacteria can extend into the renal tissues, resulting in the presence of air. This may encompass conditions such as necrotizing fasciitis and gas gangrene.</p>
        <p><bold>Anatomic fistulas:</bold> Abnormal connections between the urinary tract and gastrointestinal tract or other structures can allow the air to enter the renal parenchyma.</p>
        <p><bold>Xanthogranulomatous pyelonephritis:</bold> This condition is a&#x000a0;chronic, destructive form of pyelonephritis that can lead to renal parenchymal destruction. Although it may not typically involve gas formation, it can share some clinical features with EPN.</p>
        <p><bold>Iatrogenic causes:</bold> Procedures such as percutaneous nephrostomy or surgical interventions may introduce air into the renal parenchyma.</p>
      </sec>
      <sec id="article-155434.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>EPN&#x000a0;is a life-threatening condition&#x000a0;associated with septic complications that require urgent attention. In a systematic review&#x000a0;of 37 studies encompassing 1145 cases of&#x000a0;EPN and pyelitis, the overall pooled mortality rate was 12.5 %. However,&#x000a0;mortality rates varied&#x000a0;based on the severity of the disease.<xref ref-type="bibr" rid="article-155434.r14">[14]</xref>&#x000a0;Higher mortality rates are associated with extensive disease and its correlation with confusion, thrombocytopenia, severe proteinuria, hypoalbuminemia, hyponatremia, acute kidney injury, and septic shock.</p>
        <p>The Huang and Tseng classification system has shown a correlation between a higher class, indicating more extensive disease, with an increased risk of unfavorable outcomes.<xref ref-type="bibr" rid="article-155434.r11">[11]</xref></p>
      </sec>
      <sec id="article-155434.s10" sec-type="Complications">
        <title>Complications</title>
        <p>EPN can lead to&#x000a0;various severe complications, including the formation of renal abscesses, acute renal failure, perinephric spread of infection, pneumoperitoneum, septic shock, multiple organ failure, and recurrence.<xref ref-type="bibr" rid="article-155434.r24">[24]</xref></p>
      </sec>
      <sec id="article-155434.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with risk factors, especially those with diabetes, should be educated about the condition and symptoms that warrant medical attention.&#x000a0;Early diagnosis and management of urinary tract infections, combined with good glycemic control, can help prevent the development of emphysematous pyelonephritis.<xref ref-type="bibr" rid="article-155434.r25">[25]</xref></p>
        <p>Specific measures can be adopted and practiced to prevent urinary tract infections, including maintaining proper hygiene, urinating before and immediately after intercourse, and staying hydrated. By doing so, introducing bacteria into the urinary tract can potentially be stopped, and the progression to EPN can be prevented.</p>
      </sec>
      <sec id="article-155434.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Collaboration among physicians, nurses, pharmacists, and other hospital staff is essential for the care of patients with EPN. Healthcare providers must, first and foremost, possess the necessary clinical skills and expertise for diagnosing, evaluating, and treating this condition.&#x000a0;This involves proficiency in recognizing symptoms, interpreting radiological findings, initiating treatment promptly, and identifying potential complications. Patients diagnosed with EPN should receive combined treatment from a urologist and an infectious disease specialist.&#x000a0;Interventional radiology may be necessary for percutaneous drainage in cases requiring the drainage of gas and purulent material.</p>
        <p>A strategic approach based on evidence-based guidelines and individualized care plans tailored to each patient's unique circumstances is vital. Effective communication among interprofessional healthcare professionals fosters a collaborative environment that shares information,&#x000a0;encourages questions, and promptly addresses concerns, especially in critical, life-threatening conditions. Coordination among team members minimizes errors, reduces delays, and enhances patient safety. This approach ultimately results in improved outcomes and patient-centered care, prioritizing the well-being and satisfaction of those affected.</p>
      </sec>
      <sec id="article-155434.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=155434&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=155434">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/emphysematous-pyelonephritis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=155434">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/155434/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=155434">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-155434.s14">
        <fig id="article-155434.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Emphysematous Pyelonephritis. CT features of left-sided emphysematous pyelonephritis (axial cut). Nasr AA, Kishk AG, Sadek EM, Parayil SM. A case report of emphysematous pyelonephritis as a first presentation of diabetes mellitus. Iran Red Crescent Med J. 2013;15(12):e10384. doi:10.5812/ircmj.10384, and is available under a Creative Commons Attribution License 3.0.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Emphysematous__pyelonephritis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-155434.s15">
        <title>References</title>
        <ref id="article-155434.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smitherman</surname>
                <given-names>KO</given-names>
              </name>
              <name>
                <surname>Peacock</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Infectious emergencies in patients with diabetes mellitus.</article-title>
            <source>Med Clin North Am</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>79</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-77</page-range>
            <pub-id pub-id-type="pmid">7808095</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Falagas</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Alexiou</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Giannopoulou</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Siempos</surname>
                <given-names>II</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis.</article-title>
            <source>J Urol</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>178</volume>
            <issue>3 Pt 1</issue>
            <fpage>880</fpage>
            <page-range>880-5; quiz 1129</page-range>
            <pub-id pub-id-type="pmid">17631348</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koch</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Johnsen</surname>
                <given-names>NV</given-names>
              </name>
            </person-group>
            <article-title>The Diagnosis and Management of Life-threatening Urologic Infections.</article-title>
            <source>Urology</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>156</volume>
            <fpage>6</fpage>
            <page-range>6-15</page-range>
            <pub-id pub-id-type="pmid">34015395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Manikandan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dorairajan</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Sreenivasan</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Bokka</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Emphysematous pyelonephritis: Does a standard management algorithm and a prognostic scoring model optimize patient outcomes?</article-title>
            <source>Urol Ann</source>
            <year>2019</year>
            <season>Oct-Dec</season>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>414</fpage>
            <page-range>414-420</page-range>
            <pub-id pub-id-type="pmid">31649464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thapa</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bhusal</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Candidal emphysematous pyelonephritis: A case report on rare and challenging clinical entity.</article-title>
            <source>IJU Case Rep</source>
            <year>2021</year>
            <month>Jul</month>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>259</fpage>
            <page-range>259-262</page-range>
            <pub-id pub-id-type="pmid">34258544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schutz</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Zabott</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Boaretto</surname>
                <given-names>RBB</given-names>
              </name>
              <name>
                <surname>Toyama</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Morais</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Moroni</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Emphysematous pyelonephritis caused by C. glabrata.</article-title>
            <source>J Bras Nefrol</source>
            <year>2022</year>
            <season>Jul-Sep</season>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>447</fpage>
            <page-range>447-451</page-range>
            <pub-id pub-id-type="pmid">33760910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Somani</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Nabi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Thorpe</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hussey</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>N'Dow</surname>
                <given-names>J</given-names>
              </name>
              <collab>ABACUS Research Group</collab>
            </person-group>
            <article-title>Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review.</article-title>
            <source>J Urol</source>
            <year>2008</year>
            <month>May</month>
            <volume>179</volume>
            <issue>5</issue>
            <fpage>1844</fpage>
            <page-range>1844-9</page-range>
            <pub-id pub-id-type="pmid">18353396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lu</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Chiang</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Pong</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Hsueh</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Pu</surname>
                <given-names>YS</given-names>
              </name>
            </person-group>
            <article-title>Recommended Initial Antimicrobial Therapy for Emphysematous Pyelonephritis: 51 Cases and 14-Year-Experience of a Tertiary Referral Center.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2016</year>
            <month>May</month>
            <volume>95</volume>
            <issue>21</issue>
            <fpage>e3573</fpage>
            <pub-id pub-id-type="pmid">27227920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karthikeyan</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Manohar</surname>
                <given-names>CMS</given-names>
              </name>
              <name>
                <surname>Mallya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Keshavamurthy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kamath</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Clinical profile and successful outcomes of conservative and minimally invasive treatment of emphysematous pyelonephritis.</article-title>
            <source>Cent European J Urol</source>
            <year>2018</year>
            <volume>71</volume>
            <issue>2</issue>
            <fpage>228</fpage>
            <page-range>228-233</page-range>
            <pub-id pub-id-type="pmid">30038815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>CK</given-names>
              </name>
            </person-group>
            <article-title>Emphysematous pyelonephritis: classification, management, and prognosis.</article-title>
            <source>Tzu Chi Med J</source>
            <year>2022</year>
            <season>Jul-Sep</season>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>297</fpage>
            <page-range>297-302</page-range>
            <pub-id pub-id-type="pmid">35912050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Tseng</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis.</article-title>
            <source>Arch Intern Med</source>
            <year>2000</year>
            <month>Mar</month>
            <day>27</day>
            <volume>160</volume>
            <issue>6</issue>
            <fpage>797</fpage>
            <page-range>797-805</page-range>
            <pub-id pub-id-type="pmid">10737279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pontin</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Current management of emphysematous pyelonephritis.</article-title>
            <source>Nat Rev Urol</source>
            <year>2009</year>
            <month>May</month>
            <volume>6</volume>
            <issue>5</issue>
            <fpage>272</fpage>
            <page-range>272-9</page-range>
            <pub-id pub-id-type="pmid">19424175</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ubee</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>McGlynn</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fordham</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Emphysematous pyelonephritis.</article-title>
            <source>BJU Int</source>
            <year>2011</year>
            <month>May</month>
            <volume>107</volume>
            <issue>9</issue>
            <fpage>1474</fpage>
            <page-range>1474-8</page-range>
            <pub-id pub-id-type="pmid">20840327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Desai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Batura</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis.</article-title>
            <source>Int Urol Nephrol</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>54</volume>
            <issue>4</issue>
            <fpage>717</fpage>
            <page-range>717-736</page-range>
            <pub-id pub-id-type="pmid">35103928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Michaeli</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mogle</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Perlberg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Heiman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Caine</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Emphysematous pyelonephritis.</article-title>
            <source>J Urol</source>
            <year>1984</year>
            <month>Feb</month>
            <volume>131</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203-8</page-range>
            <pub-id pub-id-type="pmid">6366247</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wan</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Bullard</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Acute gas-producing bacterial renal infection: correlation between imaging findings and clinical outcome.</article-title>
            <source>Radiology</source>
            <year>1996</year>
            <month>Feb</month>
            <volume>198</volume>
            <issue>2</issue>
            <fpage>433</fpage>
            <page-range>433-8</page-range>
            <pub-id pub-id-type="pmid">8596845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hsueh</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Ko</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Yen</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Liao</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YS</given-names>
              </name>
            </person-group>
            <article-title>Consensus statement on the role of fluoroquinolones in the management of urinary tract infections.</article-title>
            <source>J Microbiol Immunol Infect</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>44</volume>
            <issue>2</issue>
            <fpage>79</fpage>
            <page-range>79-82</page-range>
            <pub-id pub-id-type="pmid">21439507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kapoor</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Muruganandham</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gulia</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Singla</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Agrawal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mandhani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ansari</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Srivastava</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis.</article-title>
            <source>BJU Int</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>105</volume>
            <issue>7</issue>
            <fpage>986</fpage>
            <page-range>986-9</page-range>
            <pub-id pub-id-type="pmid">19930181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Misgar</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Mubarik</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Wani</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Bashir</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Ramzan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Laway</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Emphysematous pyelonephritis: A 10-year experience with 26 cases.</article-title>
            <source>Indian J Endocrinol Metab</source>
            <year>2016</year>
            <season>Jul-Aug</season>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>475</fpage>
            <page-range>475-80</page-range>
            <pub-id pub-id-type="pmid">27366713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ciccarese</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Brandi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Corcioni</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Golfieri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gaudiano</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Complicated pyelonephritis associated with chronic renal stone disease.</article-title>
            <source>Radiol Med</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>126</volume>
            <issue>4</issue>
            <fpage>505</fpage>
            <page-range>505-516</page-range>
            <pub-id pub-id-type="pmid">33245481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aboumarzouk</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Narahari</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Coulthard</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kynaston</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chlosta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Somani</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Emphysematous pyelonephritis: Time for a management plan with an evidence-based approach.</article-title>
            <source>Arab J Urol</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>106</fpage>
            <page-range>106-15</page-range>
            <pub-id pub-id-type="pmid">26019934</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khaira</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rana</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bhalla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Khullar</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis.</article-title>
            <source>Int Urol Nephrol</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>41</volume>
            <issue>4</issue>
            <fpage>959</fpage>
            <page-range>959-66</page-range>
            <pub-id pub-id-type="pmid">19404766</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Batirel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Regmi</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mert</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Konety</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Urological infections in the developing world: an increasing problem in developed countries.</article-title>
            <source>World J Urol</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>38</volume>
            <issue>11</issue>
            <fpage>2681</fpage>
            <page-range>2681-2691</page-range>
            <pub-id pub-id-type="pmid">32108257</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Min</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Ko</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>JU</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YB</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Won</surname>
                <given-names>YD</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YO</given-names>
              </name>
            </person-group>
            <article-title>Emphysematous pyelonephritis initially presenting as a spontaneous subcapsular hematoma in a diabetic patient.</article-title>
            <source>Kidney Res Clin Pract</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>150</fpage>
            <page-range>150-3</page-range>
            <pub-id pub-id-type="pmid">26877965</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155434.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fatima</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Muthukrishnan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gude</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nath</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Shekhar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Narayan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mandal</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Ramsubbarayudu</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Emphysematous pyelonephritis: A single center study.</article-title>
            <source>Indian J Nephrol</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>119</fpage>
            <page-range>119-24</page-range>
            <pub-id pub-id-type="pmid">23716918</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
